
β Back to PACB Overview
Pacific Biosciences of California, Inc. (PACB)
Price-to-Earnings Ratio History
P/E Ratio (TTM)
-3.50
Financial Fundamentals
PACB β’ Quarterly Data β’ 5Y View
Quarterly P/E
| Quarter | P/E Ratio |
|---|---|
| 2009-09-30 | -0.17 |
| 2009-12-31 | -0.15 |
| 2010-03-31 | -0.08 |
| 2010-06-30 | -0.08 |
| 2010-09-30 | -0.10 |
| 2010-12-31 | -5.76 |
| 2011-03-31 | -5.32 |
| 2011-06-30 | -6.95 |
| 2011-09-30 | -1.49 |
| 2011-12-31 | -1.69 |
| 2012-03-31 | -1.71 |
| 2012-06-30 | -1.34 |
| 2012-09-30 | -1.13 |
| 2012-12-31 | -1.10 |
| 2013-03-31 | -1.59 |
| 2013-06-30 | -1.94 |
| 2013-09-30 | -4.41 |
| 2013-12-31 | -5.02 |
| 2014-03-31 | -4.81 |
| 2014-06-30 | -5.69 |
| 2014-09-30 | -9.44 |
| 2014-12-31 | -7.51 |
| 2015-03-31 | -5.37 |
| 2015-06-30 | -9.02 |
| 2015-09-30 | 37.79 |
| 2015-12-31 | -182.48 |
| 2016-03-31 | -9.18 |
| 2016-06-30 | -8.38 |
| 2016-09-30 | -11.79 |
| 2016-12-31 | -4.63 |
| 2017-03-31 | -5.03 |
| 2017-06-30 | -3.39 |
| 2017-09-30 | -6.90 |
| 2017-12-31 | -3.70 |
| 2018-03-31 | -2.62 |
| 2018-06-30 | -5.19 |
| 2018-09-30 | -6.93 |
| 2018-12-31 | -8.97 |
| 2019-03-31 | -9.12 |
| 2019-06-30 | -9.46 |
| 2019-09-30 | -6.78 |
| 2019-12-31 | -2161.21 |
| 2020-03-31 | 93.02 |
| 2020-06-30 | -5.75 |
| 2020-09-30 | -17.37 |
| 2020-12-31 | 16.10 |
| 2021-03-31 | -18.51 |
| 2021-06-30 | -41.63 |
| 2021-09-30 | 78.07 |
| 2021-12-31 | -16.02 |
| 2022-03-31 | -6.15 |
| 2022-06-30 | -3.47 |
| 2022-09-30 | -4.24 |
| 2022-12-31 | -5.48 |
| 2023-03-31 | -7.96 |
| 2023-06-30 | -11.87 |
| 2023-09-30 | -7.96 |
| 2023-12-31 | -7.92 |
| 2024-03-31 | -3.15 |
| 2024-06-30 | -0.47 |
| 2024-09-30 | -1.91 |
| 2024-12-31 | 54.61 |
| 2025-03-31 | -0.21 |
| 2025-06-30 | -2.22 |
| 2025-09-30 | -2.53 |
| 2025-12-31 | -3.50 |
* P/E ratios are calculated using trailing twelve-month (TTM) earnings.